According to a study published by Insure Insights, the global subdermal contraceptive implant is anticipated to grow at a CAGR of 3.9% during the forecast period. The subdermal contraceptive implant is a tiny and thin rod that is used to release hormones at a slow and stable pace into the body to prevent pregnancy. The implant is considered to prevent pregnancy for one to five years. The protection period of the implant depends on factors such as the type of polymer used and specific progestin. It offers several advantages such as long-term contraceptive action without requiring the provider’s or user’s attention, fertility reversible after the removal of the implant, and a low dose of highly effective contraception without estrogen.

Top Driver: Rising Abortion Incidences and Advantages Offered by the Implant

The major factors driving the subdermal contraceptive implant global market are the rising adoption of various advanced contraceptive methods, increasing government initiatives, growing awareness about family planning and sexual health. Rising unexpected pregnancies and rising incidence in the number of abortions are compelling the government to add healthcare costs, thereby driving the market. Another factor driving the growth of the market is several benefits offered by subdermal contraceptive implants such as high effectivity, cost-efficiency, speedy return of the natural fertility once removed the implant, and useful to women who are allergic to estrogen.

Etonogestrel Implant to Make Crucial Contribution to Growth of Global Subdermal Contraceptive Implant Market

The global subdermal contraceptive implant market can be segmented on the basis of type Etonogestrel Implant, Levonorgestrel Implant, Others. The Etonogestral implant segment accounted for a larger share in the market since the implant is considered to be safe during breastfeeding and helps to improve symptoms in endometriosis and dysmenorrhea. On the basis of application, the market is segmented into Hospitals, Clinics, Others. Hospitals segment is expected to the largest segment in the application.

  Rising In The Number Of Abortions to Benefit North America Market

North America is anticipated to gain the largest share in the global subdermal contraceptive implants market in the coming years. The rise in the number of abortions would propel the industry in the forecast period. The increase in the number of unwanted pregnancies would help the industry to boost in the forecast period. The growth in the presence of key market players in the region is expected to gain market growth. The greater affordability and growth in demand for technologically advanced products. The Asia Pacific is likely to experience strong growth during the forecast period due to the surge in the adoption of new products propelling market growth. The increase in awareness about contraceptives and STIs is expected to grow in the near future.

Players to Focus on Subdermal Contraceptive Implant Market

The global market is expected to stay fragmented with the increase in the number of new entrants in the coming years. Bayer, Merck & Co. Inc., Shanghai Dahua Pharmaceutical among others could be at the forefront of the competition in the global market.

Shanghai Dahua Pharmaceutical Co., Ltd.: In February 2018, Shanghai Dahua Pharmaceutical Co., Ltd. and DKT International entered into an agreement to market Levoplant at a reduced price of USD 6.90 per unit in 69 countries.

Bayer AG: In August 2020, Bayer AG agreed to pay US$1.6 billion to resolve most of the US litigation over its now-withdrawn Essure contraceptive device, which some women said caused excessive bleeding and pelvic pain or failed to prevent pregnancies.

Scope of the Report

By Type

• Etonogestrel Implant
• Levonorgestrel Implant
• Others

By Application

• Hospitals
• Clinics
• Others

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.